Emma Foreman

8PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersComparative and cross-cultural educationGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 21, 2023
Multiple cardiotoxicities during osimertinib therapy.

Hasan Kobat, Michael Davidson, Islam Elkonaissi

|Apr 26, 2022
Histamine-2 (H2 ) antagonists can be safely removed from standard paclitaxel premedication regimens.

Emma Foreman, Calum Polwart, Andrew Walker

|Feb 15, 2022
Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity: are real-world studies the way forward?

Hasan Kobat, Islam Elkonaissi, Emma Foreman

|Apr 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership survey.

Alexandre Chan, Himanshu Patel, Jim Siderov

|Apr 10, 2020
International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.

Morgan B Frazer, Joseph Bubalo, Himanshu Patel

|Apr 10, 2020
Preface.

Emma Foreman, Alexandre Chan

Pageof 2

Frequent Collaborators

3 joint publications

Himanshu Patel

2 joint publications

Alexandre Chan

2 joint publications

Hasan Kobat

1 joint publications

Mário De Lemos